CUV 1.12% $14.99 clinuvel pharmaceuticals limited

Thought I might mention a bit about broker reports - the...

  1. 7,705 Posts.
    lightbulb Created with Sketch. 2797
    Thought I might mention a bit about broker reports - the downgrade to a HOLD from BUY (with price target unchanged at ~$37) was cited as the reason for CUV shares falling more than 20%. That is a fallacy,

    ROTFL. Mitsubishi Tanabe are likely have a competing product MT-7117 on the market within three years. They are already in Phase 3 trials for EPP and Phase 2 for Systemic Sclerosis.

    https://www.mt-pharma.co.jp/e/develop/pipeline.html



    HC the Number One source for crackpot conspiracy theories.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.99
Change
-0.170(1.12%)
Mkt cap ! $748.6M
Open High Low Value Volume
$15.20 $15.20 $14.81 $606.5K 40.47K

Buyers (Bids)

No. Vol. Price($)
10 170 $14.97
 

Sellers (Offers)

Price($) Vol. No.
$14.99 63 5
View Market Depth
Last trade - 13.51pm 18/09/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.